Azelastine
From Wikipedia, the free encyclopedia
![]() |
|
Azelastine
|
|
Systematic (IUPAC) name | |
4-[(4-chlorophenyl)methyl]-2- (1-methylazepan-4-yl)-phthalazin-1-one | |
Identifiers | |
CAS number | |
ATC code | R01 R06AX19, S01GX07 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C22H24ClN3O |
Mol. mass | 381.898 g/mol |
Pharmacokinetic data | |
Bioavailability | 40% (intranasal) |
Metabolism | ? |
Half life | 22 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | intranasal, ocular |
Azelastine is an antihistamine and mast cell stabilizer available as a nasal spray (Astelin®) for hay fever and as eye drops (Optivar®) for allergic conjunctivitis.
Contents |
[edit] Side effects
[edit] Nasal spray
Side effects of azelastine nasal spray vary somewhat depending on the condition being treated. The most common side effects include bitter taste, headache, rhinitis, nose bleed, and somnolence. Adults being treated for vasomotor rhinitis may also experience dysesthesia and sinusitis. Additional side effects experienced by adults being treated for seasonal allergies include nasal burning, pharyngitis, dry mouth, paroxysmal sneezing, nausea, fatigue, dizziness, and weight gain.[1]